Home / Speakers / Stephen Friend

Stephen Friend

Dr Stephen Friend was on the faculty at Harvard Medical School from 1987-1995, Massachusetts General Hospital from 1990-1995 and University of Washington before becoming a Full Member at the Fred Hutchinson Cancer Research Center in 1995. He and Dr. Leland Hartwell founded and co-led the ‘Seattle Project’, an institute that linked genetics and drug discovery that developed a method for examining large patterns of genes which provided detailed functional snapshots linking yeast and man allowing researchers to intuit cellular activity directly from data versus using hypothesis-driven, narrative approaches to Biology. By 1997 the Seattle Project evolved into Rosetta Inpharmatics, where he was the CEO and President. Rosetta developed cutting edge tools to generate and analyze high-dimensional functional genomics data, matching genetic variation and function to drug response. Merck & Company acquired Rosetta in 2001 and integrated its approach across the global pharmaceutical enterprise with him as Senior Vice President and Franchise Head for Oncology Research. In 2009, he and Dr. Eric Schadt co-founded Sage Bionetworks, a non-profit organization with a goal to create a global integrative bionetwork community where researchers and the public are rewarded for collaborating and sharing their data, knowledge and insights. He is actively engaging the community to crowd-source solutions to complex biomedical questions through targeted open DREAM analysis challenges and working on projects such as “The Resilience Project”.